stockrowRhythm Pharmaceuticals, Inc.
RYTM Healthcare Biotechnology
Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.
- Revenue
- +79.6%
- EPS
- +26.9%
- Free cash flow
- +95.4%
Quarter to September 2026, against a year earlier
Follow RYTM
Alert me
Rhythm Pharmaceuticals, Inc. (RYTM) Operating cash flow
Rhythm Pharmaceuticals, Inc.'s operating cash flow for fiscal 2025 was −$115.7M, compared with −$113.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$81.8M. Over the past ten years it has ranged from −$173.4M (fiscal 2022) to −$7.0M (fiscal 2015); the current reading is higher than 55% of that period. Rhythm Pharmaceuticals, Inc. ranks 423rd of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$115.7M | — |
| FY2024 | −$113.9M | — |
| FY2023 | −$136.2M | — |
| FY2022 | −$173.4M | — |
| FY2021 | −$146.0M | — |
| FY2020 | −$122.0M | — |
| FY2019 | −$122.8M | — |
| FY2018 | −$62.1M | — |
| FY2017 | −$29.5M | — |
| FY2016 | −$23.2M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | −$3.1M | — |
| Jun 2026 | −$9.2M | — |
| Mar 2026 | −$44.2M | — |
| Dec 2025 | −$25.4M | — |
| 38 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| CORT Corcept Therapeutics Incorporated compare | $198.1M |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −$59.1M |
| AXSM Axsome Therapeutics, Inc. compare | −$81.8M |
| RYTM Rhythm Pharmaceuticals, Inc. | −$81.8M |
| ORKA Oruka Therapeutics, Inc. compare | −$100.9M |
| ABVX Abivax SA Sponsored ADR compare | −$225.9M |
| PRAX Praxis Precision Medicines, Inc. compare | −$305.1M |
| IONS Ionis Pharmaceuticals, Inc. compare | −$496.4M |
| CYTK Cytokinetics, Incorporated compare | −$572.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on RYTM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement